These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 11227893)

  • 1. Treatment with agmatine inhibits Cryptosporidium parvum infection in infant mice.
    Moore D; Waters WR; Wannemuehler MJ; Harp JA
    J Parasitol; 2001 Feb; 87(1):211-3. PubMed ID: 11227893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral dosing of neonatal mice with sucrose reduces infection with Cryptosporidium parvum.
    Harp JA
    J Parasitol; 1999 Oct; 85(5):952-5. PubMed ID: 10577733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpected activity of beta-cyclodextrin against experimental infection by Cryptosporidium parvum.
    Castro-Hermida JA; Freire-Santos F; Oteiza-Löpez AM; Ares-Mazás E
    J Parasitol; 2000 Oct; 86(5):1118-20. PubMed ID: 11128490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of benzimidazoles against cryptosporidiosis in neonatal BALB/c mice.
    Fayer R; Fetterer R
    J Parasitol; 1995 Oct; 81(5):794-5. PubMed ID: 7472880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance P receptor antagonism for treatment of cryptosporidiosis in immunosuppressed mice.
    Robinson P; Martin P; Garza A; D'Souza M; Mastrangelo MA; Tweardy D
    J Parasitol; 2008 Oct; 94(5):1150-4. PubMed ID: 18576802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cryptosporidium parvum in vitro by 9-(alkylthio)acridine derivatives.
    Khalifa L; Rosales MJ; Mascaro C; Karolak-Wojciechowska J; Bsiri N; Brouant P; Barbe J
    Arzneimittelforschung; 2000 Feb; 50(2):163-6. PubMed ID: 10719621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum.
    Urban JF; Fayer R; Chen SJ; Gause WC; Gately MK; Finkelman FD
    J Immunol; 1996 Jan; 156(1):263-8. PubMed ID: 8598471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of beta-cyclodextrin against experimental cryptosporidiosis in neonatal lambs.
    Castro-Hermida JA; González-Losada Y; Freire-Santos F; González-Warleta M; Mezo-Menéndez M; Ares-Mazás E
    J Parasitol; 2002 Feb; 88(1):185-7. PubMed ID: 12053962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pomegranate (Punica granatum) peel is effective in a murine model of experimental Cryptosporidium parvum.
    Al-Mathal EM; Alsalem AM
    Exp Parasitol; 2012 Jul; 131(3):350-7. PubMed ID: 22580265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous interleukin-12 (IL-12) exacerbates Cryptosporidium parvum infection in gamma interferon knockout mice.
    Smith LM; Bonafonte MT; Campbell LD; Mead JR
    Exp Parasitol; 2001 Jul; 98(3):123-33. PubMed ID: 11527435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral and intraperitoneal administration of phosphorothioate oligodeoxynucleotides leads to control of Cryptosporidium parvum infection in neonatal mice.
    Barrier M; Lacroix-Lamandé S; Mancassola R; Auray G; Bernardet N; Chaussé AM; Uematsu S; Akira S; Laurent F
    J Infect Dis; 2006 May; 193(10):1400-7. PubMed ID: 16619188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of calves with a vaccine against Cryptosporidium parvum.
    Harp JA; Goff JP
    J Parasitol; 1995 Feb; 81(1):54-7. PubMed ID: 7876978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral administration of putrescine inhibits Cryptosporidium parvum infection of neonatal C57BL-6 mice and is independent of nitric oxide synthesis.
    Waters WR; Reinhardt TA; Harp JA
    J Parasitol; 1997 Aug; 83(4):746-50. PubMed ID: 9267420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of paromomycin in immunosuppressed adult mice infected with Cryptosporidium parvum.
    Healey MC; Yang S; Rasmussen KR; Jackson MK; Du C
    J Parasitol; 1995 Feb; 81(1):114-6. PubMed ID: 7876965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved efficacy of dinitroaniline analogs for use as anti-cryptosporidial drugs.
    Mead JR; Benbow JW; Garmon D; Stewart J
    J Eukaryot Microbiol; 1999; 46(5):62S-63S. PubMed ID: 10519250
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of dehydroepiandrosterone in immunosuppressed adult mice infected with Cryptosporidium parvum.
    Rasmussen KR; Healey MC; Cheng L; Yang S
    J Parasitol; 1995 Jun; 81(3):429-33. PubMed ID: 7776129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New potential therapies for cryptosporidiosis: an analysis of variables affecting drug efficacy.
    Rehg J
    Folia Parasitol (Praha); 1994; 41(1):23-6. PubMed ID: 8050751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of cryptosporidium parvum oocysts in immunodeficient C57BL/6 mice.
    Alak JI; Wolf BW; Mdurvwa EG; Pimentel-Smith GE; Kolavala S; Abdelrahman H; Suppiramaniam V
    Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):855-63. PubMed ID: 10541481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapeutic effect of azithromycin and lasalocid on Cryptosporidium infection in mice.
    Kimata I; Uni S; Iseki M
    J Protozool; 1991; 38(6):232S-233S. PubMed ID: 1667931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.